Medifast, Inc. operates in the Pharmaceutical preparations sector. Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. The product lines include weight and disease management, meal replacement, and vitamins. The Company offers a range of weight and disease management products under the Medifast and Essential brand and for select private label customers. The Medifast line includes Medifast 55 Shakes, Medifast 70 Shakes, Medifast Plus for Appetite Suppression Shakes, Medifast Plus for Women's Health Shakes, Medifast Plus for Diabetics Shakes, Medifast Plus for Joint Health Shakes, Medifast Plus for Coronary Health Shakes and Essential 1 Calorie Burn Drinks. The Company's operations are primarily conducted through five of its wholly owned subsidiaries: Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSFL), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. In
our complete report available for purchase the company is compared to: Emergent BioSolutions, Inc., K-V Pharmaceutical Company and Auxilium Pharmaceuticals, Incorporation.